Literature DB >> 14641068

Glycation in food and metabolic transit of dietary AGEs (advanced glycation end-products): studies on the urinary excretion of pyrraline.

A Foerster1, T Henle.   

Abstract

Pyrraline [epsilon-(2'-formyl-5'-hydroxymethyl-pyrrolyl)-L-norleucin] belongs to the group of AGEs (advanced glycation end-products) formed in the final stage of the Maillard reaction in foods and in vivo. As it is generally accepted that AGEs are pathophysiologically relevant in aging and in diseases such as diabetes and uraemia, physiological consequences resulting from the ingestion of dietary AGEs are discussed, but balance studies for well defined AGEs are still lacking. The aim of our study was to investigate the influence of nutrition on the urinary excretion of pyrraline. After the first day without dietary restrictions, seven healthy volunteers were asked, starting on the morning of day 2, to ingest a diet virtually free of Maillard compounds (i.e. no cooked or roasted foods, no bakery products, no coffee, etc.). Dietary control was stopped on the morning of day 5. We collected 24 h urine samples for these 5 days, which were analysed for free pyrraline by reverse-phase HPLC with UV detection at 297 nm. We found that urinary excretion of free pyrraline was directly affected by the composition of the diet, decreasing from 4.8+/-1.1 mg/day on day 1 to levels of 1.6, 0.4 and 0.3 mg/day on days 2, 3 and 4 respectively, followed by a significant increase to 3.2+/-1.4 mg/day on the 5th day. The results of this work prove, for the first time, that urinary excretion of pyrraline is strongly dependent on its dietary intake. Thus the influence of nutrition should be taken into consideration in studies directed to the physiological role of glycation compounds.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14641068     DOI: 10.1042/bst0311383

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  21 in total

1.  Systemic activation of NF-κB driven luciferase activity in transgenic mice fed advanced glycation end products modified albumin.

Authors:  Norbert Nass; Kristina Bayreuther; Andreas Simm
Journal:  Glycoconj J       Date:  2017-02-13       Impact factor: 2.916

2.  Comprehensive analysis of maillard protein modifications in human lenses: effect of age and cataract.

Authors:  Mareen Smuda; Christian Henning; Cibin T Raghavan; Kaid Johar; Abhay R Vasavada; Ram H Nagaraj; Marcus A Glomb
Journal:  Biochemistry       Date:  2015-04-07       Impact factor: 3.162

Review 3.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

Review 4.  Dietary Advanced Glycation End Products and Cardiometabolic Risk.

Authors:  Claudia Luévano-Contreras; Armando Gómez-Ojeda; Maciste Habacuc Macías-Cervantes; Ma Eugenia Garay-Sevilla
Journal:  Curr Diab Rep       Date:  2017-08       Impact factor: 4.810

5.  Prognostic potential and tumor growth-inhibiting effect of plasma advanced glycation end products in non-small cell lung carcinoma.

Authors:  Babett Bartling; Hans-Stefan Hofmann; Antonia Sohst; Yvonne Hatzky; Veronika Somoza; Rolf-Edgar Silber; Andreas Simm
Journal:  Mol Med       Date:  2011-05-24       Impact factor: 6.354

6.  Diet-Derived Advanced Glycation End Products (dAGEs) Induce Proinflammatory Cytokine Expression in Cardiac and Renal Tissues of Experimental Mice: Protective Effect of Curcumin.

Authors:  Boopathi Sowndhar Rajan; Kalaiselvi Krishnan; Elangovan Vellaichamy
Journal:  Cardiovasc Toxicol       Date:  2021-10-16       Impact factor: 3.231

Review 7.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease.

Authors:  Qibin Zhang; Jennifer M Ames; Richard D Smith; John W Baynes; Thomas O Metz
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

8.  Measurement of Lens Autofluorescence for Diabetes Screening.

Authors:  Alin Stirban
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

9.  Acute macrovascular dysfunction in patients with type 2 diabetes induced by ingestion of advanced glycated β-lactoglobulins.

Authors:  Alin Stirban; Paraskevi Kotsi; Knut Franke; Ulf Strijowski; Weijing Cai; Christian Götting; Diethelm Tschoepe
Journal:  Diabetes Care       Date:  2012-12-13       Impact factor: 19.112

Review 10.  Vascular Effects of Dietary Advanced Glycation End Products.

Authors:  Alin Stirban; Diethelm Tschöpe
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.